News | Heart Failure | September 20, 2019

Max and Debra Ernst Heart Center Opening at Beaumont Hospital, Royal Oak

New gift amounts to $8 million of giving to Beaumont from Max and Debra Ernst

Max and Debra Ernst Heart Center Opening at Beaumont Hospital, Royal Oak

September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept. 30. It is dedicated to consolidating cardiac care, particularly for patients with heart failure, into a convenient and comprehensive area.

Through this $5 million gift, Orchard Lake residents Max and Debra Ernst increased their support to Beaumont heart and vascular care to a total of $8 million. In 2009, the couple also gave $3 million to open the Ernst Cardiovascular Center in Memory of Ellen Ernst.

The new center includes:

“Through their incredible support to Beaumont for more than a decade, Max and Debra have demonstrated a commitment and desire to help others in our community. It has been an honor to work with them on this project,” said Marc Sakwa, M.D., chief, cardiovascular surgery, Beaumont, Royal Oak.

The 14,000-square-foot Max and Debra Ernst Heart Center is adjacent to the East Tower entrance of the hospital near the Ernst Cardiovascular Center. The new $9 million center not only combines outpatient heart services into one dedicated space; particularly those with heart failure, but also helps patients better manage their condition and reduce emergency center visits and hospital readmissions. 

“Max and Debra’s generosity has helped us to create an amazing resource that will allow us to better serve our patients, especially those living with heart failure,” said Simon Dixon, M.D., chair, cardiovascular medicine, Beaumont, Royal Oak.

Board-certified cardiologists, advanced practice providers, trained cardiac nurses, social workers and dietitians will provide medication monitoring, heart failure management and progressive therapies to not only improve symptoms, but also enhance quality of life. These services will be delivered with compassionate and specialized patient and family-centered care, in a convenient and easily accessible location for patients requiring more support.

The first Ernst multidisciplinary center offers innovative, collaborative approaches for the treatment of complex heart and vascular conditions, in addition to preventative heart screenings. The success of the first Ernst center created the need for expansion. Since the center opened in 2010, specialists have cared for more than 30,000 patients. It has become one of the nation’s premier programs for structural heart and valve disease and cardiac surgery.  

For more information: www.beaumont.org


Related Content

News | Atrial Fibrillation

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
News | Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
Home
News | Atrial Fibrillation

February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 27, 2024
Home
News | Atrial Fibrillation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
News | Atrial Fibrillation

February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home February 02, 2024
Home
News | Atrial Fibrillation

January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed ...

Home January 18, 2024
Home
News | Atrial Fibrillation

December 29, 2023 — Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety ...

Home December 29, 2023
Home
News | Atrial Fibrillation

December 26, 2023 — Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX ...

Home December 26, 2023
Home
News | Atrial Fibrillation

December 22, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home December 22, 2023
Home
News | Atrial Fibrillation

December 14, 2023 — Medtronic plc, a global leader in healthcare technology, today announced that the United States Food ...

Home December 14, 2023
Home
Subscribe Now